It is also reported that inhibition of the human p38MAPK protein(s) decreases palmitate-induced insulin resistance of HepG2 cells in cell culture [66], suggesting that regulation of p38MAPK may play a role in treatment of T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.